TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive PRI Purchased By DynCorp; NCI Is Assured No Changes Will Be Made At Frederick April 13, 1990